[{"NetIncomeLoss_1_Q2_USD":-46885000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":20449000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":10216000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":49515562.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":50018462.0,"AccruedLiabilitiesCurrent_0_Q2_USD":30475000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":21.17,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":54434000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":31200000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":51571000.0,"Depreciation_2_Q2_USD":6105000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":96512000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_2_Q2_shares":1547627.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":0.0,"AssetsCurrent_0_Q2_USD":260196000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":72199000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":1000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":-55000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":125617000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":36267000.0,"Assets_0_Q2_USD":327592000.0,"UnrealizedGainLossOnInvestments_1_Q2_USD":-55000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":23.32,"StockGrantedDuringPeriodValueSharebasedCompensation_1_Q2_USD":2503000.0,"Investments_0_Q2_USD":36267000.0,"Liabilities_0_Q2_USD":79808000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":57351000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":21.07,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":-3093000.0,"PrepaidExpenseCurrent_0_Q2_USD":8192000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":3337000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":1146000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":425000.0,"AccountsReceivableNetCurrent_0_Q2_USD":19205000.0,"CommonStockValue_0_Q2_USD":534000.0,"Revenues_2_Q2_USD":33939000.0,"ShareBasedCompensation_2_Q2_USD":9587000.0,"Revenues_1_Q2_USD":20257000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":99177000.0,"CostsAndExpenses_2_Q2_USD":126694000.0,"CostsAndExpenses_1_Q2_USD":67567000.0,"IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_2_Q2_USD":-1476000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-91608000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-46940000.0,"OtherAssetsNoncurrent_0_Q2_USD":23509000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":196532000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":25653000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":980924000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_2_Q2_USD":7400000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":106245000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":20.9,"IncreaseDecreaseInOtherCurrentLiabilities_2_Q2_USD":1443000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":4134978.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-733691000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":70060000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":6461000.0,"CommonStockSharesOutstanding_0_Q2_shares":53365003.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":6954436.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":17000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":5136000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-80688000.0,"LiabilitiesCurrent_0_Q2_USD":45894000.0,"AccountsPayableCurrent_0_Q2_USD":2766000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":196532000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":2400000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q2_USD":51498000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":-995000.0,"AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0_Q2_USD":17000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":247784000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":329592.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":23276000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":43887000.0,"NetIncomeLoss_2_Q2_USD":-91609000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":7274540.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":401000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":36250000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1847000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":8.3,"CommonStockSharesAuthorized_0_Q2_shares":125000000.0,"OperatingIncomeLoss_2_Q2_USD":-92755000.0,"OperatingIncomeLoss_1_Q2_USD":-47310000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2_Q2_USD":2600000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":9267000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":12.67,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":7.31,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":96512000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":327592000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":5095000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":650489.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3386000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":0.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.85,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.94,"OtherLiabilitiesNoncurrent_0_Q2_USD":1442000.0,"StockholdersEquity_0_Q2_USD":247784000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q2_USD":0.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":6819000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":9587000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-3767000.0,"Ticker":"MGNX","CIK":"1125345","name":"MACROGENICS INC","OfficialName":"MacroGenics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"504089511.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200731"}]